These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17068159)

  • 1. Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.
    Nitescu N; Grimberg E; Ricksten SE; Marcussen N; Nordlinder H; Guron G
    Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1117-24. PubMed ID: 17068159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin inhibition with melagatran does not attenuate renal ischaemia-reperfusion injury in rats.
    Nitescu N; Grimberg E; Ricksten SE; Marcussen N; Guron G
    Nephrol Dial Transplant; 2007 Aug; 22(8):2149-55. PubMed ID: 17405786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose candesartan improves renal blood flow and kidney oxygen tension in rats with endotoxin-induced acute kidney dysfunction.
    Nitescu N; Grimberg E; Guron G
    Shock; 2008 Aug; 30(2):166-72. PubMed ID: 18091574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigs.
    Eriksson M; Saldeen T; Mattsson C; Larsson A
    Acta Anaesthesiol Scand; 2000 Jan; 44(1):24-31. PubMed ID: 10669267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin B receptors preserve renal blood flow in a normotensive model of endotoxin-induced acute kidney dysfunction.
    Nitescu N; Grimberg E; Ricksten SE; Herlitz H; Guron G
    Shock; 2008 Mar; 29(3):402-9. PubMed ID: 17693943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin-II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin-induced acute kidney injury.
    Nitescu N; Grimberg E; Guron G
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1170-5. PubMed ID: 20880186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis?
    Leithäuser B; Fassbender M; Eickhoff M; Elg M; Eichner G; Matthias FR
    Clin Hemorheol Microcirc; 2007; 36(4):277-89. PubMed ID: 17502698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxy-PTIO, a scavenger of nitric oxide, selectively inhibits the increase in medullary perfusion and improves renal function in endotoxemia.
    Millar CG; Thiemermann C
    Shock; 2002 Jul; 18(1):64-8. PubMed ID: 12095136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia.
    Cheng X; Leung SW; Lo LS; Pang CC
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):372-9. PubMed ID: 12690429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig.
    Eriksson M; Larsson A; Saldeen T; Mattsson C
    Thromb Haemost; 1998 Dec; 80(6):1022-6. PubMed ID: 9869178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT).
    Cvirn G; Cimenti C; Kutschera J; Ferstl U; Wagner T; Muntean W; Jurgens G; Gallistl S; Koestenberger M
    Eur J Pediatr; 2007 May; 166(5):427-31. PubMed ID: 17047995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1400W and/or nitroglycerin on renal oxygenation and kidney function during endotoxaemia in anaesthetized rats.
    Johannes T; Mik EG; Klingel K; Goedhart PT; Zanke C; Nohé B; Dieterich HJ; Unertl KE; Ince C
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):870-9. PubMed ID: 19413586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation.
    Giraud S; Thuillier R; Belliard A; Hebrard W; Nadeau C; Milin S; Goujon JM; Manguy E; Mauco G; Hauet T; Macchi L
    Transplantation; 2009 Jun; 87(11):1636-44. PubMed ID: 19502954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes.
    Gustafsson D; Antonsson T; Bylund R; Eriksson U; Gyzander E; Nilsson I; Elg M; Mattsson C; Deinum J; Pehrsson S; Karlsson O; Nilsson A; Sörensen H
    Thromb Haemost; 1998 Jan; 79(1):110-8. PubMed ID: 9459334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Wåhlander K; Eriksson-Lepkowska M; Frison L; Fager G; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):755-64. PubMed ID: 12846596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice.
    Wang H; Liu H; Jia Z; Olsen C; Litwin S; Guan G; Yang T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F754-62. PubMed ID: 20032118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats.
    Furugohri T; Fukuda T; Tsuji N; Kita A; Morishima Y; Shibano T
    Eur J Pharmacol; 2012 Jul; 686(1-3):74-80. PubMed ID: 22546231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable pharmacokinetics and pharmacodynamics of melagatran in Japanese and caucasian volunteers after oral administration of the direct thrombin inhibitor ximelagatran.
    Wernevik LC; Nyström P; Andersson M; Johnsson G; Bylock A; Nakanishi T; Eriksson UG
    Clin Pharmacokinet; 2006; 45(1):85-94. PubMed ID: 16430313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers.
    Dorani H; Schützer KM; Sarich TC; Wall U; Logren U; Ohlsson L; Eriksson UG
    Eur J Clin Pharmacol; 2007 Jun; 63(6):571-81. PubMed ID: 17387462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.